SCHEMBL21200577

SCHEMBL21200577

CCOC(=O)c1cn[nH]c1CBr

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.62
ALDH1A1 P00352 4/20 0.62
MEN1 O00255 3/20 0.62
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
GAA P10253 2/20 0.46
TSHR P16473 2/20 0.44
MAPT P10636 3/20 0.43
CYP4F2 P78329 1/20 0.43
CYP4A11 Q02928 1/20 0.43
LMNA P02545 2/20 0.41
PDE4D Q08499 1/20 0.40
PDE4B Q07343 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7519074 0.85 KMT2A (0.64) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL10719430 0.85 KMT2A (0.64) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL2324062 0.84 ALDH1A1 (0.67) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL11200214 0.84 ALDH1A1 (0.62) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL21607839 0.84 ALDH1A1 (0.62) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL3356506 0.84 KMT2A (0.62) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL20268155 0.84 ALDH1A1 (0.62) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL23302081 0.81 KMT2A (0.59) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL16211814 0.81 KMT2A (0.63) KMT2AALDH1A1MEN1NPC1RAB9A
SCHEMBL23301502 0.81 ALDH1A1 (0.63) KMT2AALDH1A1MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319756-A1 CBL-B MODULATORS AND USES THEREOF Nimbus Clio, Inc. (US) 2024-02-14 EP disclosed
WO-2023126951-A1 INHIBITORS OF AUTOPHAGY-RELATED PROTEIN-PROTEIN INTERACTIONS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2023-07-06 WO disclosed
WO-2022217276-A1 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2022-10-13 WO disclosed
EP-3897623-A1 AMINO-ACID ANILIDES AS SMALL MOLECULE MODULATORS OF IL-17 Leo Pharma A/S (DK) 2021-10-27 EP disclosed
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 EP disclosed
WO-2020127685-A1 AMINO-ACID ANILIDES AS SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2020-06-25 WO disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 WO disclosed